Skip to main content
Premium Trial:

Request an Annual Quote

HTG Molecular Preliminary 2020 Revenues Drop 56 Percent

NEW YORK – HTG Molecular on Tuesday reported a nearly 55 percent year-over-year drop in preliminary revenues for 2020.

The Tucson, Arizona-based firm said that preliminary revenues for 2020 are expected to be $8.5 million compared with $19.2 million in 2019. On average, analysts are expecting HTG to report 2020 revenues of about $8.0 million.

HTG also said that it expects to have cash, cash equivalents, and short-term marketable securities of about $28.7 million.

"Clearly COVID-19 impacted our core oncology business as planned studies were delayed and operations in many of our customers' laboratories suspended or significantly curtailed," John Lubniewski, CEO of HTG, said in a statement. "Despite these challenges, we saw returning strength in our core business in the second half and especially in the fourth quarter of 2020."

As part of HTG's plans for its whole-transcriptome gene expression profiling platform, Lubniewski noted that it has signed multiple letters of intent with potential collaborators for its early-access program in December. The firm aims to fully launch the platform later this year.

HTG, which completed a 1-for-15 reverse stock split of its outstanding stock in November, expects to announce full financial results for 2020 in March.

HTG's stock was up about 2 percent at $4.08 in early-morning trading.

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.